PJS Pharma Private Limited
About PJS Pharma Private Limited
Data last updated:
PJS Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24296TG2015PTC101062. Its GSTIN is 36AAICP2992F1Z5 (Telangana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Sreenivas Bommagani and Prasanna Lakshmi Palle.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No.103/1 Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2023, the company reported a revenue of ₹70.55 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5.21 Lakh (net margin -7.4%) and EBITDA of -₹54,836 (EBITDA margin -0.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 36% over five years.
Its group structure includes 1 subsidiary.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
PJS Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.103/1 Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of PJS Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of PJS Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of PJS Pharma Private Limited, buy the company report.
Financials of PJS Pharma Private Limited
FY 2023 filings availablePJS Pharma Private Limited reported revenue of ₹70.55 Lakh (up 5595% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years. EBITDA rose 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹54,836 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.8% | ||||
| Net Profit Margin | -7.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of PJS Pharma Private Limited, buy the company report.
Board of directors of PJS Pharma Private Limited
PJS Pharma has 6 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreenivas Bommagani Also directs: Aimchem Pharma Private Limited | Director | 08 Oct 2015 | 11 Years 0 Months | Current |
| Prasanna Lakshmi Palle | Director | 08 Oct 2015 | 11 Years 0 Months | Current |
| Vasantha Madhava Sharma Gangavaram Also directs: Aimchem Pharma Private Limited, Yajushi Chemistry Solutions LLP | Director | 15 Sep 2018 | 8 Years 1 Months | Current |
| Prabhakar Rao Pasem Also directs: Yajushi Chemistry Solutions LLP | Director | 15 Sep 2018 | 8 Years 1 Months | Current |
| Narsimha Reddy Bommineni Also directs: Indo-Swiss Remedies Private Limited | Director | 15 Sep 2018 | 8 Years 1 Months | Current |
| Sudhakar Rao Kota Also directs: Aimchem Pharma Private Limited | Director | 20 Apr 2018 | 8 Years 6 Months | Current |
Auditor
PJS Pharma Private Limited is audited by NAMBURU & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAMBURU & ASSOCIATES | FY 2018 | 012714S |
Shareholding
The shareholding of PJS Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of PJS Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving PJS Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for PJS Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
PJS Pharma has 1 subsidiary company. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Aimchem Pharma Private Limited | U24100TG2018PTC122882 |
To see the full group structure of PJS Pharma Private Limited, buy the company report.
GST
PJS Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICP2992F1Z5 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of PJS Pharma Private Limited, buy the company report.
Recent activity
PJS Pharma Private Limited has 9 board changes on record since 2015: 6 appointments and 3 cessations. The latest: Kondreddi Ravinder Reddy ceased to be Director on 05 Aug 2023.
Frequently asked questions
PJS Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 October 2015 (11+ years old) and is registered under CIN U24296TG2015PTC101062.
PJS Pharma has 6 current directors:
- Sreenivas Bommagani - Director
- Prasanna Lakshmi Palle - Director
- Vasantha Madhava Sharma Gangavaram - Director
- Prabhakar Rao Pasem - Director
- Narsimha Reddy Bommineni - Director
- Sudhakar Rao Kota - Director
The latest financial statements of PJS Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of PJS Pharma is 36AAICP2992F1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of PJS Pharma is U24296TG2015PTC101062. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
PJS Pharma was incorporated on 08 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kondreddi Ravinder Reddy ceased to be Director on 05 Aug 2023. Narsimha Reddy Bommineni was appointed as Director on 15 Sep 2018. Prabhakar Rao Pasem was appointed as Director on 15 Sep 2018. PJS Pharma has 9 board changes on record in total.
The registered office of PJS Pharma is at Plot No.1031 Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051.
PJS Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of PJS Pharma is compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
